Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (VERIFICATION Study)

NCT07715279 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07715279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07715279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (VERIFICATION Study)
Lead sponsor
West China Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
September 24, 2026
Completion date
November 30, 2029
Enrollment
238 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve diseases, aortic valve stenosis, calcific aortic valve disease